DAICITEM

This brand name is authorized in Nigeria.

Active ingredients

The drug DAICITEM contains a combination of these active pharmaceutical ingredients (APIs):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether
2	Lumefantrine UNII F38R0JR742 - LUMEFANTRINE
	Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6649	Tablet	DAICITEM TABLETS TAB 80 mg; 480 mg 16	DAICITEM TABLETS (ARTEMETHER 80MG + LUMEFANTRINE 480MG) ARTEMETHER 80MG + LUMEFANTRINE 480MG ARTEMETHER 80MG, LUMEFANTRINE 480MG, SODIUM STARCH GLYCOLATE 74MG, MICROCRYSTALLINE CELLULOSE 20MG, HPMC 200MG, TALCUM 7MG, MAGNESIUM STEARATE 120MG B4-6649 Drugs Imported Products 16 Over The Counter (OTC) 10/08/2021 DAITECH PHARMACEUTICALS LTD, BLOCK B4, COUNTESS COURT, MABUSHI, ABUJA, FCT, NIGERIA 92919163 daitechpharma@gmail.com JIANGSU PENGYAO PHARM CO. LTD, 10, CHAQUAN ROAD, YIXING CITY, JIANGSU PROVINCE CHINA, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF01	Artemether and lumefantrine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6649